Bevacizumab for the treatment of intraretinal cystic spaces in a patient with gyrate atrophy of the choroid and retina.

CONCLUSION: Repeated intravitreal bevacizumab injections can result in anatomical and functional improvement of intraretinal cystic spaces in patients with gyrate atrophy of the choroid and retina. PMID: 30335551 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30335551?dopt=Abstract

Source: Ophthalmic Genetics - October 20, 2018 Category: Opthalmology Tags: Ophthalmic Genet Source Type: research